Iron chelation down-regulates dopamine transporter expression by decreasing mRNA stability and increasing endocytosis in N2a cells

Exp Cell Res. 2011 Feb 15;317(4):405-12. doi: 10.1016/j.yexcr.2010.12.006. Epub 2010 Dec 11.

Abstract

Cell surface expression of the dopamine transporter (DAT) is determined by the relative rates of its internalization and recycling. Changes in the cellular labile iron pool (LIP) affect many cellular mechanisms including those that regulate DAT trafficking. In this study, we analyzed DAT expression and posttranslational modifications in response to changes in cellular iron in transfected neuroblastoma cells (N2a). Iron chelation by desferrioxamine (DFO) altered DAT protein levels by decreasing the stability of DAT mRNA. Increased phosphorylation and ubiquitination of this transporter protein following DFO treatment were also observed. Cellular iron depletion elevated protein levels of the early endosomal marker Rab5. Moreover, confocal microscopy studies showed increased localization of DAT into the endosomal compartment in DFO-treated cells compared to control. Together, these findings suggest that cellular iron depletion regulates DAT expression through reducing mRNA stability as well as an increasing in endocytosis.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Cell Line, Tumor
  • Deferoxamine / pharmacology
  • Dopamine Plasma Membrane Transport Proteins / genetics*
  • Down-Regulation / drug effects
  • Down-Regulation / genetics
  • Endocytosis / drug effects*
  • Endosomes
  • Humans
  • Iron / metabolism*
  • Iron / physiology
  • Iron Chelating Agents / pharmacology*
  • Neuroblastoma
  • RNA Stability / drug effects*
  • Transfection

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Iron Chelating Agents
  • Iron
  • Deferoxamine